You are on page 1of 8

IMPACT OF DPCO POLICIES ON INDIAN PHARMACEUTICAL INDUSTRY

Raahul Dahake 01

.  Method of implementation of prices fixed by Government and penalties for contravention of provisions . 1955 to regulate the prices of drugs.The Drugs Price Control Order (DPCO). The Order provides The list of price controlled drugs  Procedures for fixation of prices of drugs. 1995 is an order issued by the Government of India under Section 3 of the Essential Commodities Act.

 Strengthening the indigenous capability for production of drugs. at reasonable prices of essential and life saving and medicines of good quality.  Creating an environment friendly to channelizing new investment into the pharmaceutical industry with an objective to boost cost-effective production with economic sizes and introducing new technologies and new drugs.  .  Strengthening the quality control system over drugs and medicines production and promoting the rational use of drugs in the country.Providing abundant quantity.

1995 includes following drugs       SULPHAMETHOXAZOLE PENICILLINS TETRACYCLINE RIFAMPICIN STREPTOMYCIN RANITIDINE                                 VITAMIN C BETAMETHASONE METRONIDAZOLE CHLOROQUINE INSULIN ERYTHROMYCIN VITAMIN A OXYTETRACYCLINE PREDNISOLONE CEPHAZOLIN METHYLDOPA ASPIRIN TRIMETHOPRIM CLOXACILLIN SULPHADIMIDINE SALBUTAMOL FAMOTIDINE IBUPROFEN METAMIZOL (ANALGIN) DOXYCYCLINE CIPROFLOXACIN CEFOTAXIME DEXAMETHASONE EPHEDRINE VITAMIN B1 (THIAMINE) CARBAMAZEPINE VITAMIN B2 (RIBOFLAVIN) THEOPHYLLINE LEVODOPA TOLNAFTATE VITAMIN E NALIDIXIC ACID .DPCO policy.

                   GRISEOFULVIN GENTAMICIN DEXTROPROPOXYPHENE HALOGENATED HYDROXYQUINOLINE PENTAZOCINE CAPTOPRIL NAPROXEN PYRENTAL SULPHADOXINE NORFLOXACIN CEFADROXYL PANTHONATES & PANTHENOLS FURAZOLIDONE PYRITHIOXINE SULPHADIAZINE FRAMYCETIN VERAPAMIL AMIKACIN SULPHATE * GLIPIZIDE                    SPIRONOLACTONE PENTOXYFYLLINE AMODIAQUIN SULPHAMOXOLE FRUSEMIDE PHENIRAMINE MALEATE CHLOROXYLENOLS BECAMPICILLIN LINCOMYCIN CHLORPROPAMIDE MEBHYDROLINE CHLORPROMAZINE METHENDIENONE PHENYL BUTAZONE LYNESTRANOL SALAZOSULPHAPYRINE DIOSMINE TRIMIPRAMINE MEFENAMIC ACID * .

 The DPCO policy. ( the list will be presented in final presentation) . 2012 is aimed at regulating the prices of 348 drugs that are considered essential. and combination medicines using them.

1.800 crore to Rs.  The industry will take at least two to three years to negate this impact . and could reduce profitability of the industry by around 25%. The policy will lower the prices of several medicines by 50% to 70%.  There will be immediate revenue reduction of Rs.000 crore.2.

THANK YOU .